Penumbra
PEN
#1836
Rank
S$12.03 B
Marketcap
$313.49
Share price
1.45%
Change (1 day)
21.34%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total debt

Total debt on the balance sheet as of September 2024 : S$0.30 Billion

According to Penumbra's latest financial reports the company's total debt is S$0.30 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Penumbra - Total debt on balance sheet (from 2018 to 2024)

Total debt by year

Year Total debt Change
2023-12-31S$0.30 B-2.08%
2022-12-31S$0.31 B34.72%
2021-12-31S$0.23 B129.5%
2020-12-31S$0.10 B-7.86%
2019-12-31S$0.11 B
2018-12-31N/A
2013-12-31S$7.6 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
S$43.38 M-85.56%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.08 B 261.35%๐Ÿ‡บ๐Ÿ‡ธ USA